Eventide Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,227,376
| Closed | -$91.8M | – | 166 |
|
|
2021
Q3 | $91.8M | Sell |
5,227,376
-4,282,624
| -45% | -$75.2M | 1.21% | 28 |
|
|
2021
Q2 | $92.2M | Buy |
9,510,000
+1,851,000
| +24% | +$18M | 1.24% | 29 |
|
|
2021
Q1 | $82.3M | Buy |
7,659,000
+2,877,552
| +60% | +$30.9M | 1.22% | 28 |
|
|
2020
Q4 | $70.3M | Buy |
4,781,448
+1,584,440
| +50% | +$23.3M | 1.08% | 31 |
|
|
2020
Q3 | $45.4M | Buy |
3,197,008
+650,008
| +26% | +$9.24M | 0.89% | 37 |
|
|
2020
Q2 | $20.6M | Buy |
+2,547,000
| New | +$20.6M | 0.45% | 67 |
|